| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/11/2000 | US6087355 A therapeutic bactericide composition for treating a methicillin-resistant, vancomycin-resistant, or ampicillin-resistant bacterial infection |
| 07/11/2000 | US6087339 Saccharide derivatives |
| 07/11/2000 | US6087328 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines |
| 07/11/2000 | US6087169 HKABY60: polynucleotide encoding a helix-loop-helix ubiquitous kinase family polypeptide |
| 07/11/2000 | US6087161 Recombinant polynucleotide of promoter and sequence encoding protein with translation stop codon in open reading frame at 3' end resuling in deletion of c-terminal amino acids important for vacuolar targeting; for fungi resistant plants |
| 07/11/2000 | US6087150 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4 |
| 07/11/2000 | US6087142 Valyl tRNA synthetase from streptococcus pneumoniae |
| 07/11/2000 | US6087128 DNA encoding an avian E. coli iss |
| 07/11/2000 | US6087126 Bactericidal/permeability-increasing protein (BPI) deletion analogs |
| 07/11/2000 | US6087122 Polynucleotide sequence which codes a mammalian polypeptide synthetases; for diagnosis, evaluation, prevention, and treatment of physiological defects |
| 07/11/2000 | US6087106 Nucleic acids conferring and inducible resistance to glycopeptides particularly in gram-positive bacteria |
| 07/11/2000 | US6086922 Use of a chemically-stabilized chlorite matrix for the parenteral treatment of HIV infections |
| 07/11/2000 | US6086921 Metal/thiol biocides |
| 07/11/2000 | US6086902 Recombinant bovine herpesvirus type 1 vaccines |
| 07/11/2000 | US6086901 Imunological adjuvants and antigen entrapment |
| 07/11/2000 | US6086896 Antigenic iron repressible protein from N. meningitidis related to the hemolysin family of toxins |
| 07/11/2000 | US6086895 Treatment with proteins and polypeptides |
| 07/11/2000 | US6086894 Recombinant vaccine for diseases caused by encapsulated organisms |
| 07/11/2000 | US6086893 Helicobacter lactoferrin receptor |
| 07/11/2000 | US6086892 Poultry vaccine |
| 07/11/2000 | US6086891 Plasmids |
| 07/11/2000 | US6086885 Anti-bacterial protein extracts from seeds of marigold and paprika |
| 07/11/2000 | US6086880 Peptide consists of the amino acid sequence of positions 40-60 of the rotavirus vp6 viral protein optionally modified to facilitate conjugation; useful as immunochemical, as vaccines and immunogens |
| 07/11/2000 | US6086864 Polythioureas having 3 to 50 recurring units derived from aromatic diamines substituted with anionic groups including a sulfonic acid group; water soluble, have a rigid backbone; useful for treatment and diagnosis of aids |
| 07/11/2000 | CA2082948C Immunogenic peptides, antibodies and uses thereof relating to cd4 receptor binding |
| 07/06/2000 | WO2000039327A1 Peptidoglycan recognition proteins |
| 07/06/2000 | WO2000039316A1 Transgenic rodents and rodent cell lines expressing hiv co-receptors |
| 07/06/2000 | WO2000039304A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 07/06/2000 | WO2000039303A2 Modified hiv env polypeptides |
| 07/06/2000 | WO2000039302A2 Improved expression of hiv polypeptides and production of virus-like particles |
| 07/06/2000 | WO2000039299A2 Streptococcus antigens |
| 07/06/2000 | WO2000039287A2 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides and uses thereof |
| 07/06/2000 | WO2000039285A2 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof |
| 07/06/2000 | WO2000039283A1 Use of cd40 engagement to alter t cell receptor usage |
| 07/06/2000 | WO2000039158A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000039157A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | WO2000039156A1 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 07/06/2000 | WO2000039143A2 Antiviral nucleoside analogues |
| 07/06/2000 | WO2000039142A1 Erythromycin a compounds and process for preparing the same |
| 07/06/2000 | WO2000039140A1 Siastatin b derivatives having glycosidase inhibitory activities and process for producing the same |
| 07/06/2000 | WO2000039139A1 Anti-(retro)viral conjugates of saccharides and acetamidino or guanidino compounds |
| 07/06/2000 | WO2000039125A1 Piperidines as ccr5 modulators |
| 07/06/2000 | WO2000039116A1 Aminopyrazole derivatives |
| 07/06/2000 | WO2000039110A1 Homopiperazine derivatives as selective emopamil inhibitors |
| 07/06/2000 | WO2000039095A2 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity |
| 07/06/2000 | WO2000039087A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors |
| 07/06/2000 | WO2000039086A1 Aromatic heterocycle compounds having hiv integrase inhibiting activities |
| 07/06/2000 | WO2000039083A2 Pyrazole compounds and uses thereof |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000038785A2 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | WO2000038732A1 Hyaluronate lyase used for promoting penetration in topical agents |
| 07/06/2000 | WO2000038713A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | WO2000038712A2 Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans |
| 07/06/2000 | WO2000038711A2 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
| 07/06/2000 | WO2000038697A1 Treatment and prevention of hiv and other viral infections |
| 07/06/2000 | WO2000038695A2 Aciclovir compositions containing dimethicone |
| 07/06/2000 | WO2000038687A1 Protease inhibitors |
| 07/06/2000 | WO2000038680A1 Azabicycloalkanes as ccr5 modulators |
| 07/06/2000 | WO2000038679A1 Treatment of retroviral infections with oxyphenbutazone |
| 07/06/2000 | WO2000038674A1 COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR |
| 07/06/2000 | WO2000038660A2 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | WO2000038655A1 Dosage forms comprising porous particles |
| 07/06/2000 | WO2000038653A1 Improved formulation for topical non-invasive application in vivo |
| 07/06/2000 | WO2000018430A3 Live virus vaccines to protect primates from hiv-1 infection and disease |
| 07/06/2000 | WO2000018429A3 Vaccine based on attenuated $i(haemophilus somnus) |
| 07/06/2000 | WO2000018419A3 Methods for administration of antibiotics |
| 07/06/2000 | WO2000018417A3 Treatment of hepatitis b infection with thymosin alpha 1 and lamivudine |
| 07/06/2000 | WO2000018352A3 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/06/2000 | WO2000017222A8 31 human secreted proteins |
| 07/06/2000 | WO2000015770A3 Human serine/threonine protein kinases |
| 07/06/2000 | WO2000012509A3 Collections of compounds |
| 07/06/2000 | WO1999052514A3 Pharmaceutical composition and combination preparation for immunosuppressive therapy |
| 07/06/2000 | DE19859426A1 Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen Use of organophosphorus compounds for therapeutic and prophylactic treatment of infections |
| 07/06/2000 | CA2621097A1 Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
| 07/06/2000 | CA2362492A1 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity |
| 07/06/2000 | CA2358385A1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2358047A1 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds |
| 07/06/2000 | CA2356895A1 Aciclovir compositions containing dimethicone |
| 07/06/2000 | CA2356885A1 Siastatin b derivatives having glycosidase inhibitory activities and process for producing the same |
| 07/06/2000 | CA2356671A1 Protease inhibitors |
| 07/06/2000 | CA2356661A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 07/06/2000 | CA2356622A1 Compounds which affect mrna stability and uses therefor |
| 07/06/2000 | CA2356608A1 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides abd uses thereof |
| 07/06/2000 | CA2356542A1 Peptidoglycan recognition proteins |
| 07/06/2000 | CA2356475A1 Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans |
| 07/06/2000 | CA2356262A1 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 07/06/2000 | CA2356057A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | CA2355468A1 Glycosyl phosphatidy linositol specific phospholipase d proteins and uses thereof |
| 07/06/2000 | CA2354542A1 Transgenic rodents and rodent cell lines expressing hiv co-receptors |
| 07/06/2000 | CA2354431A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/06/2000 | CA2354052A1 Methods for treating certain diseases using naaladase inhibitors |
| 07/06/2000 | CA2353961A1 Heteroaromatic derivatives having an inhibitory activity against hiv integrase |
| 07/06/2000 | CA2352423A1 Treatment of retroviral infections with oxyphenbutazone |
| 07/05/2000 | EP1016715A1 Oligonucleotides having a conserved G4 core sequence |
| 07/05/2000 | EP1016672A1 Polypeptide transition metal salts and method of enhancing anti-hiv activity of polypeptide |
| 07/05/2000 | EP1016671A2 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) |
| 07/05/2000 | EP1016670A1 Glycopeptide antibiotic derivatives |
| 07/05/2000 | EP1016669A1 New derivatives of erythromycin, process for making them as well as their use as medicaments |
| 07/05/2000 | EP1016646A1 Intermediates for the preparation of cephalosporines containing on the 7-position a substituted benzyloximino radical |